Vaccine in National
Immunization Programme
Update
March 2015
Countries with Hib vaccine in the national immunization programme;
and planned introductions in 2015
Introduced* to date
* Includes partial introduction
(192 countries or 99%)
Not Available, Not Introduced/No Plans
(2 countries or 1%)
Not applicable
Data source: WHO/IVB Database, as of 05 March 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the
expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent
approximate border lines for which there may not yet be full agreement. ©WHO 2015. All
rights reserved.
Countries using IPV vaccine to date
 This information is available from the website @:
 IPV Introduction, OPV Withdrawal and Routine Immunization
Strengthening:
http://www.who.int/immunization/diseases/poliomyelitis/in
activated_polio_vaccine/en/
 (click on the hyperlink to access the website – on its right
hand column a slide set presentation in downloadable)
Countries with Pneumococcal Conjugate vaccine in the national
immunization programme; and planned introductions in 2015
Introduced* to date
Planned introductions in 2015
* Includes partial introduction
(120 countries or 61.9%)
(10 countries or 5.2%)
Not Available, Not Introduced/No Plans by 2015
(64 countries or 33%)
Not applicable
Data source: WHO/IVB Database, as of 05 March 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the
expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent
approximate border lines for which there may not yet be full agreement. ©WHO 2015. All
rights reserved.
Countries with Rotavirus vaccine in the national immunization
programme; and planned introductions in 2015
Introduced* to date
Planned introductions in 2015
* Includes partial introduction
(77 countries or 39.7%)
(9 countries or 4.6%)
Not Available, Not Introduced/No Plans by 2015
(108 countries or 55.7%)
Not applicable
Data source: WHO/IVB Database, as of 05 March 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the
expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent
approximate border lines for which there may not yet be full agreement. ©WHO 2015. All
rights reserved.
Countries with HPV vaccine in the national immunization programme
* ncludes partial introduction but not countries
where vaccination is temporarily interrupted
Introduced* to date
(63 countries or 32.5%)
Not Available, Not Introduced
(131 countries or 67.5%)
Not applicable
Data source: WHO/IVB Database, as of 05 March 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the
expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent
approximate border lines for which there may not yet be full agreement. ©WHO 2015. All
rights reserved.
Countries using Measles Second Dose vaccine to date; and planned
introductions in 2015
Introduced to date
Planned introductions in 2015
(153 countries or 78.9%)
( 4 countries or 2.1%)
Not Available, Not Introduced/No Plans by 2015
(37 countries or 19.1%)
Not applicable
Data source: WHO/IVB Database, as of 05 March 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the
expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent
approximate border lines for which there may not yet be full agreement. ©WHO 2015. All
rights reserved.
Countries with Rubella vaccine in the national immunization
programme; and planned introductions in 2015
Introduced to date
Planned introductions in 2015
(141 countries or 72.7%)
(7 countries or 3.6%)
Not Available, Not Introduced/No Plans by 2015
(46 countries or 23.7%)
Not applicable
Data source: WHO/IVB Database, as of 05 March 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the
expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent
approximate border lines for which there may not yet be full agreement. ©WHO 2015. All
rights reserved.
Countries and Territories using Yellow fever* vaccine to date
* WHO considers that 48 countries/Territories
are at risk for Yellow fever
Introduced to date
Introduced in High risk areas
(33 countries or 69%)
(4 countries or 8%)
At risk but not introduced
(11 countries or 23%)
Not Available / Not at risk
(147 countries or 76%)
Not applicable
Data source: WHO/IVB Database, as of 19 December 2014
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the
expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent
approximate border lines for which there may not yet be full agreement. ©WHO 2014. All
rights reserved.
Countries and Territories using JE vaccine to date
At risk countries/areas but not
introduced
(21 countries or 48%)
Introduced to date
(7 countries/territories or 30%)
Introduced in parts of the
country
(5 countries or 22%)
Not applicable
Data source: WHO/IVB Database, as of 19 December 2014
International travel Health Database
(http://www.who.int/wer/2013/wer8834.pdf?ua=1)
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the
expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent
approximate border lines for which there may not yet be full agreement. ©WHO 2014. All
rights reserved.